click below
click below
Normal Size Small Size show me how
unit 4 meds
| Question | Answer |
|---|---|
| iron salts | Stored as ferritin in the body Used in Iron deficiency anemia (RBCs are microcytic and hypochromic) Prescription and over the counter (OTC) |
| Oral Iron | Ferrous gluconate, Ferrous sulfate, Ferrous fumarate 1 hour before meals Decrease absorption: Antacids, abx and thyroid drugs, foods containing milk, some grains and cereals Increase absorption :Vitamin C Liquid iron must be admin with a straw |
| IV/IM Iron | (Iron dextran) Used when oral is unsatisfactory or impossible Z-track administration required |
| Iron Side effects | GI: upset stomach, n&v, diarrhea, constipation Dark, tarry stools Skin: discoloration of skin/teeth and pain upon injection Nursing considerations: Monitor for side effects Give iron 1 hour before meals preferably |
| educate abt iron | roper admin and medications that increase and decrease absorption Importance of adequate food sources to maintain iron (lean meats, liver, egg yolks, dried beans, green veggies) Educate on expected stool changes |
| vitamin b12 | deficiency affects neuro, hematologic and GI systems Used to treat pernicious anemia (megaloblastic, macrocytic anemia) Pts with GI surgeries that remove all or part of stomach will require lifelong injections |
| Cyanocobalamin (Vitamin B12 injectable) | IM or deep SQ admin Z-track admin for IM Protect from light |
| Cyanocobalamin (Vitamin B12) side effects | Flushing, diarrhea, itching/pain at injection site |
| Cyanocobalamin (Vitamin B12) considerations | Monitor therapeutic level for Vitamin B12 (Schilling test) Rotate sites for parenteral admin and use Z-track Protect injection from light Monitor K+ level Educate on food sources of B12 |
| s/s of B12 deficiency | (numbness/tingling in extremities, weakness, fatigue, anorexia, loss of taste, diarrhea, memory loss, mood changes) |
| folic acid folate | vitamin needed for DNA synthesis/cell division Deficiency associated with neural tube defects in fetus and megaloblastic macrocytic anemia Oral replacement for a deficiency/ preventative in pregnancy 0.4mg/day maintenance and 1mg/day therapeutic |
| folic acid folate effects | Yellow discoloration of urine, nausea, altered sleep, depression, rash, bronchospasm Nursing considerations Educate patient that alcohol consumption decreases folic acid levels Educate on food sources |
| hydroxyurea | Antineoplastic agent Used in polycythemia vera (bone marrow suppression) Used in sickle cell (decreases sickled cells and reduces hemolysis) Pregnancy category D PO Side effects Bone marrow suppression, stomatitis, rash |
| hydroxyurea considerations | Determine status of kidney, liver and bone marrow function Monitor I&O, increase fluid intake |
| clotting factors | Factor VIII Used to treat Hemophilia A Factor IX Used to treat Hemophilia B, Cryoprecipitate Concentrated form of fibrinogen, obtained from fresh frozen plasma (FFP) |
| Desmopressin acetate (DDAVP) clotting factor | Antidiuretic hormone with additive effect of increasing Factor VIII Used in Hemophilia A and Von Willebrand disease Intranasal, IV, SQ Contraindicated in pregnancy Short lived, used pre-procedural |
| anticoaugulants | Agents that prevent or delay blood coagulation Warfarin (PO) Heparin (IV, SQ) Low-molecular weight Heparin (SQ) Dalteparin Enoxaparin |
| Selective Factor Xa Inhibitors (PO, SQ) | Rivaroxaban Fondaparinux Apixaban Edoxaban |
| Heparin | Works on thrombin; prevents fibrinogen to fibrin SQ for VTE prevention IV for VTE treatment (requires q6-8h PTT monitoring) Protamine Sulfate: antidote Prolongs activated Partial Thromboplastin Time (PTT) |
| Low-molecular-weight Heparin—Enoxaparin (Lovenox) | SQ Prevents Prothrombin to thrombin Risk for HIT lower, unless previously on heparin |
| Vitamin K antagonists - Warfarin (Coumadin) | Interferes with synthesis of Vit-K dependent clotting factors Does not effect existing clotting factors Vitamin K: antidote Monitor PT & INR Give same time everyday, Do not change brands, diet teaching (Vitamin K) |
| Selective factor Xa inhibitors | Fondaparinux (Arixtra) SQ Rivaroxaban (Xarelto) and apixaban (Eliquis) PO VTE prevention and treatment Coag monitoring not required Produces rapid anticoagulation |
| Aspirin antiplatelet | PO, most commonly used, cheap Used in PAD, CAD, MI, stroke, VTE Give on full stomach to minimize GI upset |
| Clopidogrel antiplatelet | PO Added in pts with stroke, MI, and PAD |
| Cilostazol antiplatelet | PO Reduces symptoms of intermittent claudication |
| Teach: avoid herbs that can | increase risk of bleeding (garlic, chamomile, gingko, turmeric, golden seal, green leaf tea Teach to monitor for s/s of bleeding, bruising and anemia |
| ACE inhibitors | Maintain tight BP control, reduce PAD symptoms |
| Antiplatelets | Critical for reducing cardiovascular disease risk and death Includes ASA 81mg May add Clopidogrel for high risk patients Anticoagulants NOT RECOMMENDED in PAD |
| Cilostazol | Phosphodiesterase inhibitor Inhibits platelet aggregation and increases vasodilation |
| Pentoxifylline | Xanthine derivative Improves flexibility of blood cells and decreases platelet adhesiveness Not as effective as cilostazol and not used often |
| Calcium channel blockers | (nifedipine, diltiazem, verapamil, amlodipine) Relaxes smooth muscle and prevents arterial spasm Used in Raynaud’s, HTN Monitor for hypotension and headache |
| Corticosteroids (prednisone, methylprednisolone) | give with food Anti-inflammatory and immunosuppressive activity Used in ITP (immune thrombocytopenic purpura), TTP (thrombocic thrombocytopenic purpura), aplastic anemia, asthma, COPD, pneumonia Monitor glucose, WBC, platelets |
| anticoagulant vs antiplatelet | antiplatelets (e.g., aspirin) keep platelets from clumping, primarily preventing arterial clots (heart attacks/strokes). Anticoagulants (e.g., Warfarin, Eliquis) slow the body’s clotting mechanism, treating venous clots |